M. E. Botes

Statistics

Publications

Citations

330

H-Index

Active since

2012

Affiliations

Amsterdam Institute for Global Health and Development(Current)

PharmAccess Group

University of the Witwatersrand

Lagos University Teaching Hospital

International Centre for Reproductive Health Kenya

M. E. Botes is an author at Amsterdam Institute for Global Health and Development specializing in drug resistance mutations, antiretroviral therapy, and pharmacology.

ORCID

Publications per year

2012–2019

Publications

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies

Raph L Hamers, Kim Sigaloff, Annemarie M. J. Wensing et al. · Clinical Infectious Diseases · 2012 · 161 citations · Full text

Life Sciences, Pharmacology, Antimicrobial Resistance +16

Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization

Rustelle Janse van Vuuren, M. E. Botes, Tamarin Jurgens et al. · Cancer Cell International · 2019 · 88 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +17

Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa

Kim Sigaloff, Raph L Hamers, Carole L. Wallis et al. · The Journal of Infectious Diseases · 2012 · 69 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance Network

Raph L Hamers, E. Straatsma, Cissy Kityo et al. · Clinical Infectious Diseases · 2012 · 12 citations · Full text

Public Health, Infectious Disease Control, Pharmacology +17

1–4 of 4